ArticleCancers2022

Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.

Purab Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.